You searched for "evidence"

1680 results found

Otology training in low- and middle-income countries: a view from within

It is recognised that hearing loss and ear disease are far more common in less affluent parts of the world, and that those countries are often least able to provide treatment; so how can we prioritise care for these patients?...

Hearing implant devices: new expectations during IFOS 2023 ENT World Congress, Dubai

We hear from one of the senior members of the IFOS Executive Board about the aspects of IFOS that he is looking forward to – and, in particular, his focus on implantable hearing devices. From 17 to 21 January 2023,...

Hearing loss and Alport syndrome

Alport syndrome (AS) includes a group of hereditary diseases caused by mutations in the COL4A3, COL4A4 or COL4A5 genes. These genes are responsible for the biosynthesis of α3, α4 and α5 collagen IV chains, which are located in the glomerular...

Clinical WG1. Establishing a standard for tinnitus: patient assessment and characterisation

Rilana Cima and Haúla Haider introduce an ambitious pan-European collaboration that seeks to establish guidelines for achieving best clinical practice for managing, assessing and treating patients with different tinnitus profiles. Tinnitus heterogeneity is the major reason for inconsistent results in...

The lessons in setting up a community ENT service in the NHS

Sudeb Mandal, a GP with special interest in ENT, talks about the novel approach taken in the community to deliver ENT services in Kent in the UK. The Kent Community ENT service was born with the vision to bring together...

COOL therapy for cisplatin-induced hearing loss

Cisplatin is a commonly used cancer therapy, with nearly 50% of patients undergoing chemotherapy receiving cisplatin as part of their regimen [1]. Depending on the dose, incidence of hearing loss has been reported as 12-100% in adults, and 37-94% in...

Challenges in paediatric airway management

Paediatric airway emergencies are high-stakes, but training, simulation and updated guidelines help ENT teams manage risks and build confidence. Congratulations to the ENT Masterclass® on its forthcoming 20th birthday. Over the past two decades, Shahed Quraishi has grown it to...

IFOS 2023: from state-of-the art science to global inequalities

The Dubai World Trade Center will open its doors on 17 January 2023 to welcome delegates to the IFOS 2023 World ENT Congress.

Future of Hearing Healthcare virtual conference

The fifth annual Future of Hearing Healthcare Conference (FHH) will be held virtually on Wednesdays May 14, 21 and 28, continuing its mission to highlight the ideas, innovations, and individuals shaping the future of hearing care. Organised by Hearing Health...

3rd International Symposium on Inner Ear Therapeutics

L’Institut de l’Audition (Centre Pasteur, Paris) and the International Society for Inner Ear Therapeutics (ISIET), with de collaboration with ENT-HNS Moroccan Collège (CEMORL), are organising the 3rd International Symposium on Inner Ear Therapeutics entitled ‘Inner Ear Therapeutics: Updates and Challenges...

Children with Hearing Loss: Developing Listening and Talking, Birth to Six - Third Edition

I was very excited to read this book as I have seen some of Carol Flexer’s presentations on the auditory brain and the concepts have fitted well into my paediatric rehabilitation clinics, especially in relating the complexities of hearing loss...

Medical-Legal Evaluation of Hearing Loss

Robert Dobie is a highly experienced and respected international authority in the field of medical-legal assessment in the context of noise induced hearing loss. This book has been written for a broad audience, including otolaryngologists, audiologists and members of the...